These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 193451

  • 1. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH, Kuzuya H, Horwitz DL.
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [Abstract] [Full Text] [Related]

  • 2. C-peptide measurement: methods and clinical utility.
    Bonser AM, Garcia-Webb P.
    Crit Rev Clin Lab Sci; 1984 May; 19(4):297-352. PubMed ID: 6373142
    [Abstract] [Full Text] [Related]

  • 3. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
    Scarlett JA, Mako ME, Rubenstein AH, Blix PM, Goldman J, Horwitz DL, Tager H, Jaspan JB, Stjernholm MR, Olefsky JM.
    N Engl J Med; 1977 Nov 10; 297(19):1029-32. PubMed ID: 198659
    [Abstract] [Full Text] [Related]

  • 4. Insulin biosynthesis and C-peptide. Practical applications from basic research.
    Sperling MA.
    Am J Dis Child; 1980 Dec 10; 134(12):1119-21. PubMed ID: 7004174
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of circulating proinsulin and C-peptide.
    Rubenstein AH, Steiner DF, Horwitz DL, Mako ME, Block MB, Starr JI, Kuzuya H, Melani F.
    Recent Prog Horm Res; 1976 Dec 10; 33():435-75. PubMed ID: 198859
    [No Abstract] [Full Text] [Related]

  • 6. Circulating serum C-peptide. A brief review of diagnostic implications.
    Horwitz DL, Kuzuya H, Rubenstein AH.
    N Engl J Med; 1976 Jul 22; 295(4):207-9. PubMed ID: 179006
    [No Abstract] [Full Text] [Related]

  • 7. C-peptide in conditions other than diabetes mellitus.
    Horwitz DL, Rubenstein AH, Mako ME, Cruz A, Blix PM.
    Diabetes; 1978 Jul 22; 27 Suppl 1():267-71. PubMed ID: 631444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S, Zoupas C, Dimitriadis G, Moulopoulos S.
    Horm Metab Res Suppl; 1979 Jul 22; (8):169-72. PubMed ID: 231567
    [Abstract] [Full Text] [Related]

  • 12. Production of pro-insulin, C-peptide, and insulin in nesidioblastosis, focal islet-cell adenomatosis, and genuine insulomas. A correlated radioimmunochemical, immunohistochemical, and ultrastructural investigation with particular regard to the occurrence of argyrophil and pro-insulin immunoreactive cells.
    Kohnert KD, Fält K, Odselius R, Ziegler M, Madsen OD, Grimelius L, Falkmer S.
    Diabetes Res; 1988 Aug 22; 8(4):151-63. PubMed ID: 2853026
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Current concepts concerning insulin resistance].
    Rossi G.
    Recenti Prog Med; 1981 Sep 22; 71(3):264-73. PubMed ID: 7034082
    [No Abstract] [Full Text] [Related]

  • 17. [Proinsulin, C-peptide reactive protein (CPR)].
    Takahashi R, Oka Y.
    Nihon Rinsho; 2005 Aug 22; 63 Suppl 8():488-92. PubMed ID: 16149558
    [No Abstract] [Full Text] [Related]

  • 18. Secretory function of pancreatic beta cell during insulin-induced hypoglycemia evaluated by C-peptide immunoreactivity (CPR) determination.
    Shima K, Tanaka R, Morishita S, Sawazaki N, Ichihara K, Kumahara Y, Yanaihara N.
    Med J Osaka Univ; 1978 Dec 22; 29(3-4):221-8. PubMed ID: 379559
    [No Abstract] [Full Text] [Related]

  • 19. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.
    Exp Diabesity Res; 2004 Dec 22; 5(1):37-50. PubMed ID: 15198370
    [Abstract] [Full Text] [Related]

  • 20. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
    Gjessing HJ.
    Ugeskr Laeger; 1990 Feb 26; 152(9):588-93. PubMed ID: 2408222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.